Evidence map›Paper›PMID 26907955›Full record

ReviewPhysiology & behavior2016

Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Anne Q Fosnocht, Lisa A Briand

Open access · greenAbstract readReview
In one paragraph

Review in Physiology & behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment.International journal of environmental research and public health · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Observational
  15. Review
  16. Article
  17. The cannabis withdrawal syndrome: current insights.Substance abuse and rehabilitation · 2017
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Anne Q FosnochtDepartment of Psychology, Temple University, United States.
Lisa A BriandDepartment of Psychology, Temple University, United States. Electronic address: lbriand@temple.edu.
Temple College · USTemple University · US

Funding

AMPA Receptor Trafficking and Cocaine ReinstatementR00DA033372 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI BRIAND, LISA A · 2015 to 2017
$736k
NIDA NIH HHS R00 DA033372
6 · The paper itself

Abstract

Drug addiction is a major public health concern in the United States costing taxpayers billions in health care costs, lost productivity and law enforcement. However, the availability of effective treatment options remains limited. The development of novel therapeutics will not be possible without a better understanding of the addicted brain. Studies in both clinical and preclinical models indicate that chronic drug use leads to alterations in the body and brain's response to stress. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis may shed light on the ability of stress to increase vulnerability to relapse. Further, within both the HPA axis and limbic brain regions, corticotropin-releasing factor (CRF) is critically involved in the brain's response to stress. Alterations in both central and peripheral CRF activity seen following chronic drug use provide a mechanism by which substance use can alter stress reactivity, thus mediating addictive phenotypes. While many reviews have focused on how stress alters drug-mediated changes in physiology and behavior, the goal of this review is to focus on how substance use alters responses to stress.

Indexed as

AnimalsCorticotropin-Releasing HormoneHumansHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemStress, PsychologicalSubstance-Related DisordersCorticotropin-Releasing HormoneAddictionCRFHPA axisStressSubstance use

Identifiers

PMID26907955
PMCPMC4991948
OpenAlexW2280571114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.